Fierce Pharma
3 trends tracked about this subject — the full history, oldest to newest below.
↓ Cooling
Business
A major Novartis shareholder is demanding a board overhaul following a series of costly deal setbacks and failures in drug trials.
3 sources
3 articles
v 1
1h ago
◼ Archived
Business
🔮 fades ✗
AstraZeneca shares have declined following reports of potential $400 billion merger talks with Bristol Myers Squibb.
4 sources
5 articles
v 3
37d ago
◼ Archived
Business
🔮 fades ✓
Johnson & Johnson proposes a $5.5 billion settlement to potentially resolve marathon talc litigation.
1 sources
1 articles
v 1
44d ago
\n
\n
\n